Patients on heart transplant waiting list – results

Czech version

Authors: I. Málek; M. Hegarová; L. Hošková; M. Podzimková; Z. Dorazilová; T. Gazdič; I. Netuka
Published in: Kardiol Rev Int Med 2011, 13(1): 41-43
Category: From Heart Failure to Heart Transplantation

Overview

Advanced cardiac failure is a high risk period for the development of complications and patient mortality. Following inclusion on the heart-transplant waiting list, intensive efforts are necessary to minimize these risks. The following work represents a retrospective analysis of a group of patients who were examined and included on the IKEM waiting list during defined period of time. Mortality during the waiting period was 13%, two times lower than in the early stages of the programme. This positive result, achieved despite the extension of the waiting period, is an indication of the significant progress made in the conservative treatment of cardiac failure. The development of these procedures is still in progress and we believe that there is potential for yet more reduction in the mortality of patients with advanced cardiac failure.

Keywords:
heart transplant – advanced cardiac failure – waiting-list

Sources

1. Stehlík J, Edwards LB, Kucheryavaya AY et al. The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report – 2010. J Heart Lung Transplant 2010; 29: 1089–1103.

2. Málek I. Transplantace srdce. Pohled kardiologa. 1. vyd. Praha: Triton 2004: 77–79.

3. Málek I, Hegarová M. Profil pacientů na čekací listině transplantace srdce. Cor et Vasa 2010; 52: 149–153.

4. Bardy GH, Lee KL, Mark DB et al. Amiodarone or implantable defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225–237.

5. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Eng J Med 2004; 350: 2140–2150.

6. Cleland JG, Daubert JC, Erdmann E et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–1549.

7. Allman KC, Shaw LJ, Hamowitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Amer Coll Cardiol 2002; 39: 1151–1158.

8. Florian M, Kautzner J, Pirk J, Málek I. Myocardial revascularization in patiens with severe left ventricular systolic dysfunction. Cor et Vasa 2004; 46: 575–580.

9. Jones RH, Velazquez EJ, Michler RE et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009; 360: 1705–1717.

10. Kirklin JK, Naftel DC, Kormos RL et al. Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants. J Heart Lung Transpl 2010; 29: 1–12.

11. Viklický O, Janoušek L, Baláž P et al. Transplantace ledviny v klinické praxi. 1. vyd. GRADA Publishing 2008: 74-75.